FI884604A - IMPLANTERBAR, BIOLOGISKT NEDBRYTBART AKTIVMEDELS FRIGIVNINGSSYSTEM. - Google Patents

IMPLANTERBAR, BIOLOGISKT NEDBRYTBART AKTIVMEDELS FRIGIVNINGSSYSTEM. Download PDF

Info

Publication number
FI884604A
FI884604A FI884604A FI884604A FI884604A FI 884604 A FI884604 A FI 884604A FI 884604 A FI884604 A FI 884604A FI 884604 A FI884604 A FI 884604A FI 884604 A FI884604 A FI 884604A
Authority
FI
Finland
Prior art keywords
nedbrytbart
implanterbar
frigivningssystem
aktivmedels
biologiskt
Prior art date
Application number
FI884604A
Other languages
Finnish (fi)
Other versions
FI100302B (en
FI884604A0 (en
Inventor
Herbert Stricker
Guenther Entenmann
Otto Kern
Michel Mikhail
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI884604A0 publication Critical patent/FI884604A0/en
Publication of FI884604A publication Critical patent/FI884604A/en
Application granted granted Critical
Publication of FI100302B publication Critical patent/FI100302B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Abstract

The system consists of a carrier material based on poly-D,L-lactide and of a drug incorporated therein and, where appropriate pharmaceutical auxiliaries. The carrier material contains defined contents of additives in the form of pore formers, up to about 10% by weight of a physiologically acceptable solvent or plasticiser and/or low molecular weight polymers.
FI884604A 1987-10-09 1988-10-07 Poly-D, L-lactide-based carrier and method for preparing an implantable, biodegradable release system for an active substance FI100302B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3734223 1987-10-09
DE19873734223 DE3734223A1 (en) 1987-10-09 1987-10-09 IMPLANTABLE, BIODEGRADABLE ACTIVE SUBSTANCE RELEASE SYSTEM

Publications (3)

Publication Number Publication Date
FI884604A0 FI884604A0 (en) 1988-10-07
FI884604A true FI884604A (en) 1989-04-10
FI100302B FI100302B (en) 1997-11-14

Family

ID=6338006

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884604A FI100302B (en) 1987-10-09 1988-10-07 Poly-D, L-lactide-based carrier and method for preparing an implantable, biodegradable release system for an active substance

Country Status (17)

Country Link
EP (1) EP0311065B1 (en)
JP (1) JP2763303B2 (en)
KR (1) KR970006082B1 (en)
AT (1) ATE101035T1 (en)
AU (1) AU609194B2 (en)
CA (1) CA1333770C (en)
DE (2) DE3734223A1 (en)
DK (1) DK175252B1 (en)
ES (1) ES2061589T3 (en)
FI (1) FI100302B (en)
IE (1) IE62505B1 (en)
IL (1) IL87973A (en)
NO (1) NO176304C (en)
NZ (1) NZ226514A (en)
PH (1) PH30236A (en)
PT (1) PT88703B (en)
ZA (1) ZA887535B (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5424346A (en) * 1988-08-08 1995-06-13 Ecopol, Llc Biodegradable replacement of crystal polystyrene
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US5252642A (en) * 1989-03-01 1993-10-12 Biopak Technology, Ltd. Degradable impact modified polyactic acid
US5216050A (en) * 1988-08-08 1993-06-01 Biopak Technology, Ltd. Blends of polyactic acid
US5180765A (en) * 1988-08-08 1993-01-19 Biopak Technology, Ltd. Biodegradable packaging thermoplastics from lactides
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
JPH05503286A (en) * 1989-06-05 1993-06-03 マサチューセッツ インスティテュート オブ テクノロジー Bioerodible polymers for drug delivery in bone
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (en) * 1989-07-28 1992-01-15 Debiopharm Sa
WO1991011176A1 (en) * 1990-01-30 1991-08-08 Akzo N.V. Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
DE69004415D1 (en) * 1990-03-05 1993-12-09 Minnesota Mining & Mfg Device for delayed delivery of pharmacologically active compounds into the ear.
US5350580A (en) * 1990-03-05 1994-09-27 Minnesota Mining And Manufacturing Company Device and method for extended delivery of pharmacologically active agents to the ear
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
BR9808456A (en) * 1997-04-04 2000-05-23 Alcan Int Ltd Aluminum alloy composition and manufacturing process
AR012448A1 (en) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech COMPOSITION IN THE FORM OF MICROCAPSULES OR IMPLANTS COMPRISING A BIODEGRADABLE CONTAINER, POLYMER OR CO-POLYMER, OR A MIXTURE OF SUCH EXCIPIENTS, AND AN ACTIVE SUBSTANCE OR MIXTURE OF ACTIVE SUBSTANCES, PROCEDURE FOR THE PREPARATION OF A SUBSTANCE IN A SUBSTANCE
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
DE19908753C2 (en) * 1999-02-20 2003-10-02 Jenapharm Gmbh Biodegradable, injectable oligomer-polymer composition
US6306425B1 (en) * 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6702849B1 (en) 1999-12-13 2004-03-09 Advanced Cardiovascular Systems, Inc. Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers
DE60132525T2 (en) 2000-03-22 2009-01-29 Dainippon Ink And Chemicals, Inc. PEDESTALIZED MODIFYERS AND POLYESTER COMPOSITION CONTAINING THOSE MODIFIERS
EP1637126B1 (en) * 2000-07-05 2016-12-14 Allergan, Inc. Methods for treating inflammation of the eye
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
JP2004514702A (en) 2000-11-29 2004-05-20 オキュレックス　ファーマシューティカルズ，　インコーポレイテッド Intraocular implant for preventing transplant rejection in the eye
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
DE602005011928D1 (en) 2004-01-20 2009-02-05 Allergan Inc COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, PREFERABLY CONTAINING TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8512738B2 (en) 2004-04-30 2013-08-20 Allergan, Inc. Biodegradable intravitreal tyrosine kinase implants
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20050244458A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
JP2009532490A (en) 2006-04-06 2009-09-10 ヌパス インコーポレイテッド Implants for the treatment of dopamine-related conditions
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
WO2011057129A2 (en) 2009-11-09 2011-05-12 Allergan, Inc. Compositions and methods for stimulating hair growth
JP4779169B1 (en) * 2010-10-27 2011-09-28 Ｎｅｃインフロンティア株式会社 Button lighting structure, electronic equipment
WO2014127243A1 (en) 2013-02-15 2014-08-21 Allergan, Inc. Sustained drug delivery implant
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
WO2019071243A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Implantable depots for controlled release of therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (en) * 1955-12-22
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
DE3218150C2 (en) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Active substance-containing body for long-term release and process for its production
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3710175A1 (en) * 1987-02-12 1988-08-25 Hoechst Ag MULTI-PIECE IMPLANTABLE MEDICINE PREPARATION WITH LONG-TERM EFFECT

Also Published As

Publication number Publication date
CA1333770C (en) 1995-01-03
PT88703B (en) 1992-12-31
IL87973A0 (en) 1989-03-31
NZ226514A (en) 1990-02-26
EP0311065B1 (en) 1994-02-02
PH30236A (en) 1997-02-05
IL87973A (en) 1992-08-18
ATE101035T1 (en) 1994-02-15
DE3887616D1 (en) 1994-03-17
IE883040L (en) 1989-04-09
JP2763303B2 (en) 1998-06-11
DK561588A (en) 1989-04-10
DK561588D0 (en) 1988-10-07
ZA887535B (en) 1990-06-27
DE3734223A1 (en) 1989-04-20
AU2352288A (en) 1989-04-13
NO176304B (en) 1994-12-05
ES2061589T3 (en) 1994-12-16
FI100302B (en) 1997-11-14
EP0311065A1 (en) 1989-04-12
JPH02117A (en) 1990-01-05
KR970006082B1 (en) 1997-04-23
NO884474D0 (en) 1988-10-07
DK175252B1 (en) 2004-07-19
IE62505B1 (en) 1995-02-08
KR890006222A (en) 1989-06-12
FI884604A0 (en) 1988-10-07
NO884474L (en) 1989-04-10
PT88703A (en) 1988-11-01
NO176304C (en) 1995-03-22
AU609194B2 (en) 1991-04-26

Similar Documents

Publication Publication Date Title
FI884604A (en) IMPLANTERBAR, BIOLOGISKT NEDBRYTBART AKTIVMEDELS FRIGIVNINGSSYSTEM.
NZ221484A (en) Starburst polymer conjugates as carriers for agricultural, pharmaceutical and other materials
DE69019817T2 (en) Carrier material for drug administration.
NZ216082A (en) Prolonged-release microparticles
DE3884314T2 (en) Polymer blend with reverse phase morphology for controlled drug delivery.
ES2039377T3 (en) A SUPPOSITORY.
EP0307097A3 (en) Water-insolubilized cytokines
ATE94764T1 (en) NASAL APPLICABLE MEDICATION, PROCESS FOR ITS PRODUCTION AND ITS USE.
EP0380989A3 (en) Plaster for transdermal administration
DE3750656D1 (en) Catalysts for the production of polyethylene with a large molecular weight distribution.
DE69228031T2 (en) Chndromodulin-II protein
MC2102A1 (en) APPLICATION OF MIXED MICELLES
FR2610322B1 (en) NOVEL PILOCARPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES
DE3773128D1 (en) CYCLOPENTANAETHER, THEIR PRODUCTION AND PHARMACEUTICAL FORMULATION.
ATE70840T1 (en) BENZOTHIEPINO(5,4-C>PYRIDAZINE COMPOUNDS AND THEIR PHARMACEUTICAL EFFECTS.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: BOEHRINGER INGELHEIM KG

MA Patent expired